DarioHealth Corp., a blood glucose monitoring system has announced a joint marketing agreement with Glytec, a provider of insulin titration solutions. As part of the partnership, Dario Blood Glucose Monitoring System is now available to hospitals and health systems using Glytec’s virtual insulin titration service for outpatients with diabetes.Integration Details & BenefitsBlood glucose data from the Dario Blood Glucose Monitoring System automatically sent to the Cloud in real-time, will be
Read More
Impact of Diabetes Management for Patients, Payers, and Providers| News, Policy, Analysis, Insights - HIT Consultant
Amazon Choice Integrates with One Drop for Diabetes and Hypertension Management
One Drop, a provider of digital therapeutics solutions, today announced an integration partnership with Amazon’s exclusive health brand, Choice. The integration with One Drop’s app will provide Amazon’s Choice customers living with diabetes and hypertension with affordable, accessible, and comprehensive digital health management services.One Drop/Amazon Choice Integration BenefitsLaunched in late 2018, Amazon Choice was developed by Arcadia Group to offer an array of affordable medical devices
Read More
NHS England Publishes New Guidelines on Flash Glucose Monitors for Type 1 Diabetes Patients
NHS England recently published clinical guidance for flash glucose monitors that outlines funding arrangements for patients with type 1 diabetes and the qualifying criteria to support local health groups. According to NHS England, an estimated 260,000 in England suffer from type 1 diabetes.Starting in April, the NHS will provide the technology for one in five of those with type 1 diabetes in England. Those who qualify include:- People with type 1 diabetes who need intensive monitoring (more than
Read More
Fitbit Partners with Solera Health to Address Type 2 Diabetes
Fitbit, today announced its expanded partnership with Solera Health, an integrated benefit network to reduce the risk of type 2 diabetes by encouraging positive behavior changes, such as increased physical activity and weight loss.Type 2 diabetes affects more than 30 million American adults and costs the U.S. approximately $327 billion annually in direct medical expenses and lost productivity. Yet, the onset of disease can be delayed – or even prevented – among the 84 million U.S. adults at high
Read More
New Saliva Glucose Biosensor Could Eliminate Finger Pricks for Diabetes
New non-invasive, saliva-based glucose test measures glucose in saliva rather than blood could eliminate finger pricks for diabetes management.The iQ Group Global, a Sydney, Australia-based consortium of life science and financial services companies has unveiled the Saliva Glucose Biosensor, a non-invasive, saliva-based glucose test for diabetes management that measures glucose in saliva rather than blood. The saliva-based glucose test could eliminate painful finger pricks for diabetes
Read More
Abbott Integrates Insulin Dose Data with Novo Nordisk Insulin Pens
Abbott and Novo Nordisk today announced a non-exclusive partnership that will integrate insulin dose data from Novo Nordisk pre-filled and durable connected pens directly into the digital health tools compatible with the FreeStyle Libre system (FreeStyle LibreLinkii mobile app and LibreViewiii cloud-based system). The integration between Abbott and Novo Nordisk’s products will enable healthcare professionals, caregivers and people with diabetes to view glucose and insulin data together to help
Read More
FDA Authorizes Interoperable Tandem Insulin Pump for Personalized Diabetes Management
The U.S. Food and Drug Administration (FDA) has permitted marketing of the Tandem Diabetes Care t:Slim X2 insulin pump with interoperable technology (interoperable t:Slim X2) for delivering insulin under the skin for children and adults with diabetes. This new type of insulin pump, Referred to as an alternate controller enabled (ACE) infusion pump, or ACE insulin pump, is the first interoperable insulin pump, meaning it can be used with different components that make up diabetes therapy systems,
Read More
Livongo Acquires Digital Behavioral Health Solution myStrength
Livongo Health, an Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced that it has acquired Denver-based myStrength, Inc., a provider of digital behavioral health solutions. Financial terms of the acquisition were not disclosed. The acquisition enables Livongo to more fully address the health of the whole person by integrating behavioral health conditions including depression, anxiety, stress, substance use disorder,
Read More
Medtronic Acquires Nutrino Health to Integrate Diabetes Capabilities with Nutritional Data
Medtronic acquires Nutrino Health to augment diabetes capabilities with Nutrino’s nutritional database and data science. Medtronic, a provider of medical technology announced it will acquire Tel Aviv-based Nutrino Health, a provider of nutrition-related data services, analytics, and technologies. For Medtronic, the acquisition is an opportunity to improve clinical outcomes for people with diabetes through the integration of Nutrino’s extensive food analysis infrastructure, nutrition science
Read More
UCSF Launches SUGAR Clinical Trial Study to Compare Livongo’s Diabetes Management Program to Standard Diabetes Care
Applied Health Signals company Livongo Health, today announced the launch of the Study to Understand Gaining Access to Blood Glucose Records (SUGAR), or SUGAR study, a randomized controlled trial in collaboration with the University of California, San Francisco (UCSF). The aim of the clinical trial is to measure the impact of the Livongo for Diabetes program compared to the average standard of care approach to diabetes management utilizing a traditional Bluetooth glucose meter. SUGAR Study
Read More
